User:Mr. Ibrahem/Rimexolone
Appearance
Clinical data | |
---|---|
Trade names | Vexol |
Other names | Trimexolone; Org 6216; 11β-Hydroxy-16α,17α,21-trimethylpregna-1,4-dien-3,20-dione |
AHFS/Drugs.com | Monograph |
MedlinePlus | a606003 |
Routes of administration | Eye drops |
Drug class | Corticosteroid |
Pharmacokinetic data | |
Elimination half-life | estimated 1–2 hours |
Excretion | >80% faeces |
Identifiers | |
| |
Chemical and physical data | |
Formula | C24H34O3 |
Molar mass | 370.533 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Rimexolone, sold under the brand name Vexol, is a steroid medication used to treat inflammation of the eye.[1] This includes anterior uveitis and following surgery of the eye.[1] It is used as an eye drop.[1]
Common side effects include increased intraocular pressure, blurry vision, eye pain, redness, and a runny nose.[1] Other complications can include fungal infection of the cornea.[1]
Rimexolone was approved for medical use in the United States in 1994.[1] In the United States a 5 ml bottle costs about 100 USD as of 2021.[2] It is no longer available in the United Kingdom as of 2019.[3]
References[edit]
- ^ a b c d e f g h "Rimexolone Monograph for Professionals". Drugs.com. Archived from the original on 20 January 2021. Retrieved 17 October 2021.
- ^ "Vexol Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 17 October 2021.
- ^ "Rimexolone eye drops. Rimexolone antibiotic eye drops - Patient". patient.info. Archived from the original on 13 August 2021. Retrieved 17 October 2021.